Martin Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
2,906
+36
+1% +$2.9K 0.08% 46
2026
Q1
$249K Sell
2,870
-880
-23% -$84.3K 0.07% 44
2025
Q4
$360K Sell
3,750
-1,913
-34% -$186K 0.1% 41
2025
Q3
$539K Buy
5,663
+100
+2% +$9.19K 0.14% 39
2025
Q2
$485K Buy
5,563
+860
+18% +$72.9K 0.12% 39
2025
Q1
$423K Hold
4,703
0.11% 40
2024
Q4
$376K Sell
4,703
-15
-0.3% -$1.3K 0.1% 40
2024
Q3
$425K Buy
4,718
+5
+0.1% +$421 0.1% 40
2024
Q2
$371K Hold
4,713
0.1% 43
2024
Q1
$411K Sell
4,713
-9,125
-66% -$779K 0.1% 41
2023
Q4
$1.14M Buy
13,838
+998
+8% +$76.1K 0.34% 29
2023
Q3
$1.01M Sell
12,840
-205
-2% -$17.2K 0.3% 32
2023
Q2
$1.15M Buy
13,045
+160
+1% +$13.8K 0.32% 34
2023
Q1
$1.04M Hold
12,885
0.3% 35
2022
Q4
$1M Buy
12,885
+3,280
+34% +$266K 0.31% 33
2022
Q3
$776K Sell
9,605
-180
-2% -$16.2K 0.27% 33
2022
Q2
$878K Hold
9,785
0.25% 36
2022
Q1
$1.09M Buy
9,785
+3,467
+55% +$366K 0.28% 34
2021
Q4
$654K Sell
6,318
-6,157
-49% -$713K 0.16% 41
2021
Q3
$1.56M Buy
12,475
+85
+0.7% +$11K 0.39% 35
2021
Q2
$1.54M Hold
12,390
0.4% 36
2021
Q1
$1.46M Buy
12,390
+6,157
+99% +$722K 0.41% 35
2020
Q4
$730K Buy
6,233
+2
+0% +$220 0.23% 38
2020
Q3
$648K Buy
6,231
+2,798
+82% +$281K 0.23% 36
2020
Q2
$315K Sell
3,433
-139
-4% -$13.3K 0.13% 39
2020
Q1
$322K Buy
3,572
+25
+0.7% +$2.66K 0.16% 38
2019
Q4
$402K Sell
3,547
-195
-5% -$21.4K 0.14% 37
2019
Q3
$406K Hold
3,742
0.1% 37
2019
Q2
$364K Buy
3,742
+80
+2% +$7.3K 0.09% 37
2019
Q1
$334K Sell
3,662
-50
-1% -$4.47K 0.09% 37
2018
Q4
$338K Sell
3,712
-3,290
-47% -$307K 0.11% 35
2018
Q3
$689K Sell
7,002
-9
-0.1% -$832 0.19% 33
2018
Q2
$600K Hold
7,011
0.15% 33
2018
Q1
$562K Buy
7,011
+180
+3% +$14.8K 0.14% 34
2017
Q4
$531K Hold
6,831
0.15% 33
2017
Q3
$531K Hold
6,831
0.15% 33
2017
Q2
$606K Sell
6,831
-41,024
-86% -$3.46M 0.17% 31
2017
Q1
$3.85M Sell
47,855
-75,471
-61% -$5.9M 1.09% 33
2016
Q4
$8.79M Sell
123,326
-15
-0% -$1.18K 1.67% 36
2016
Q3
$10.7M Buy
123,341
+5,370
+5% +$468K 1.76% 29
2016
Q2
$10.2M Buy
117,971
+36,182
+44% +$2.93M 1.71% 28
2016
Q1
$6.13M Hold
81,789
0.96% 32
2015
Q4
$6.29M Buy
81,789
+24,332
+42% +$1.83M 1% 32
2015
Q3
$3.85M Hold
57,457
0.62% 35
2015
Q2
$4.26M Buy
57,457
+60
+0.1% +$4.58K 0.61% 32
2015
Q1
$4.48M Buy
+57,397
New +$4.35M 0.62% 33

Other funds holding MDT

Martin Investment Management's MDT Position: Q2 2026 in Review

Martin Investment Management increased its Medtronic (MDT) stake by 1.3% in Q2 2026, buying an estimated $2.9K and bringing the position to 2,906 shares worth $227K. The position accounts for 0.08% of the portfolio, ranked #46.

Martin Investment Management first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $10.7M in Q3 2016. 631 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Martin Investment Management held 2,906 shares of Medtronic worth $227K as of Q2 2026.
  • Martin Investment Management bought 36 Medtronic shares in Q2 2026, an estimated $2.9K.
  • Medtronic made up 0.08% of Martin Investment Management's portfolio in Q2 2026, its #46 holding.
  • Martin Investment Management first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
  • Martin Investment Management's Medtronic position peaked at $10.7M in Q3 2016.
  • 631 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Martin Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.